Pharma-Print: At-Home Antibody Testing and Personalized Dosage

A subscription service that provides at-home diagnostic tests using microfluidic devices linked to AI. Users receive personalized antibody dosage recommendations based on real-time health data and AI-predicted disease progression. Designed to reduce wasted medication and optimize treatment efficacy.

Future Scenarios that inspired this product idea

AI-driven platforms will accelerate the design and discovery of novel therapeutic antibodies, leading to more effective treatments for cancer and autoimmune disorders.

Extrapolated from Note on the Relationship Between Artificial Intelligence and Human Intelligence - Vatican.va